Search

Your search keyword '"Gastaldi, Matteo"' showing total 505 results

Search Constraints

Start Over You searched for: Author "Gastaldi, Matteo" Remove constraint Author: "Gastaldi, Matteo"
505 results on '"Gastaldi, Matteo"'

Search Results

52. A score that predicts aquaporin‐4‐IgG positivity in patients with longitudinally extensive transverse myelitis

53. Progressive post infectious neurological syndromes with a poor outcome: long term follow-up and neurofilament light chain quantification

54. Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study

55. Granulocyte activation markers in cerebrospinal fluid differentiate acute neuromyelitis spectrum disorder from multiple sclerosis

56. Beyond Myelin Oligodendrocyte Glycoprotein and Aquaporin-4 Antibodies: Alternative Causes of Optic Neuritis.

57. Antibodies to neurofascin, contactin-1, and contactin-associated protein 1 in CIDP: Clinical relevance of IgG isotype

58. New Materials and Technologies for Durability and Conservation of Building Heritage

62. Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: potential relevance of antibody titers in monitoring treatment response

63. Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: Potential relevance of antibody titers in monitoring treatment response.

64. Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study

65. Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD

66. AQP4-MOG Double-Positive Neuromyelitis Optica Spectrum Disorder: Case Report with Central and Peripheral Nervous System Involvement and Review of Literature

68. Neurofilament-light chain quantification by SimoaTM and EllaTM in plasma from patients with dementia: a comparative study

70. Safety profile of SARS-CoV-2 vaccination in patients with antibody-mediated CNS disorders

77. The Improvement of Durability of Reinforced Concretes for Sustainable Structures: A Review on Different Approaches

79. A case study on corrosion conditions and guidelines for repair of a reinforced concrete chimney in industrial environment.

80. Prognostic relevance of quantitative and longitudinal MOG antibody testing in patients with MOGAD: a multicentre retrospective study.

85. Combined Central and Peripheral Demyelination with Anti-Neurofascin155 IgG Following COVID-19 Vaccination

87. Characterization and management of neurological adverse events during immune-checkpoint inhibitors treatment: an Italian multicentric experience

88. The challenge of the performance-based approach for the design of reinforced concrete structures in chloride bearing environment

92. COVID‐19 in patients with myasthenia gravis: Epidemiology and disease course

95. NfL levels predominantly increase at disease onset in MOG-Abs-associated disorders

98. Inter-Laboratory Concordance of Cerebrospinal Fluid and Serum Kappa Free Light Chain Measurements.

100. Isolated bulbar palsy after SARS-CoV-2 infection

Catalog

Books, media, physical & digital resources